Exhibit 32.1

              CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly report of Meditech Pharmaceuticals, Inc. (the
"Company") on Form 10-QSB for the period ending November 30, 2004, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I ,
Gerald N. Kern, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

     (1)  The Report fully complies with the requirements of Section 13 (a) or
          15 (d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.



By:  /s/  Gerald N. Kern
   --------------------------
          Gerald N. Kern
          Chief Executive Officer


January 19, 2005